IP Library Granted Patent US 9,610,313
Granted Patent B2
US 9,610,313 · App. 14/275,968 · Granted Apr 4, 2017

Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids

Inventors: John A. Minatelli (Mount Dora, FL); W. Stephen Hill (Ocala, FL); Rudi E. Moerck (Sanford, FL); Uy Nguyen (Eustis, FL)
Assignee: U.S. NUTRACEUTICALS
A61K36/535A23D9/00A23L33/105A23L33/115A61K31/07A61K31/122A61K31/201A61K35/612A61K36/02A61K36/05A61K36/537C11B1/06C11B1/10C11B1/104C11B3/001A61K2236/15A61K2236/37
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,610,313
App. No.
14/275,968
Granted
Apr 4, 2017
Kind
B2
Abstract

A dietary supplement composition is formulated in a therapeutically effective amount to treat the eye of an individual. The composition includes a perilla seed oil extract, astaxanthin, and at least one carotenoid selected from the group consisting of lutein, trans-zeaxanthin and meso-zeaxanthin.

Claims (9)

1. A dietary supplement composition, comprising a therapeutically effective amount of a shelf stable, perilla seed oil extract derived from supercritical CO2 fluid extraction of a cracked biomass of perilla frutescens seed, astaxanthin, and lutein and trans-zeaxanthin, wherein the dietary supplement composition is formulated into a single dosage capsule, and wherein the astaxanthin is about 0.1 to 16 percent by weight of the perilla seed oil extract, the lutein is about 0.4 to 30 percent by weight of the perilla seed oil extract, and the trans-zeaxanthin is about 0.04 to 24 percent by weight of the perilla seed oil extract.

2. The composition according to claim 1 , wherein the composition comprises 0.5 to 8 mg of astaxanthin, 2 to 15 mg of lutein and 0.2 to 12 mg of trans-zeaxanthin.

3. The composition according to claim 2 , wherein the composition comprises about 4 mg of astaxanthin, about 10 mg of lutein and about 1.2 mg of trans-zeaxanthin.

4. The composition according to claim 1 , wherein the composition comprises about 50 to 500 mg of perilla seed oil extract.

5. The composition according to claim 1 , wherein the astaxanthin comprises 3S, 3′S-astaxanthin derived from Haematococcus pluvialis.

6. The composition according to claim 1 , further comprising krill oil.

7. The composition according to claim 1 , further comprising an algae based oil.

8. The composition according to claim 1 , wherein the perilla seed oil extract comprises from about 60 to 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA).

9. The composition according to claim 1 , wherein the peroxide value of the perilla seed oil extract is under 10.0 meq/Km.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2014
From: MINATELLI, JOHN A.; HILL, W. STEPHEN; MOERCK, RUDI E.; NGUYEN, UY
To: U.S. NUTRACEUTICALS, LLC, D/B/A VALENSA INTERNATIONAL
Reel/Frame 033013/0201 →
Continuity (4)
Continuation In Part 13231131 · Sep 13, 2011
Continuation In Part 12419321 · Apr 7, 2009
Provisional Application 61043773 · Apr 10, 2008
Related Publication 20140248369A1 · Sep 4, 2014